Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population (Q81306370)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

A J Barrett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M-J Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Arora

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M A Pulsipher

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

N Bunin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Fort

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

F Loberiza

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D Porter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S Giralt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

W Drobyski

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D Wang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S Pavletic

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

O Ringden

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M M Horowitz

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

R Collins

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

19 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

201-205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18490913%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2008.135

7 January 2020

exact match

0 references

cites work

Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

Modelling covariate adjusted mortality relative to a standard population

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021

Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.135

7 January 2021